These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 11752106)

  • 1. Effects of subcutaneous methylnaltrexone on morphine-induced peripherally mediated side effects: a double-blind randomized placebo-controlled trial.
    Yuan CS; Wei G; Foss JF; O'Connor M; Karrison T; Osinski J
    J Pharmacol Exp Ther; 2002 Jan; 300(1):118-23. PubMed ID: 11752106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The safety and efficacy of oral methylnaltrexone in preventing morphine-induced delay in oral-cecal transit time.
    Yuan CS; Foss JF; Osinski J; Toledano A; Roizen MF; Moss J
    Clin Pharmacol Ther; 1997 Apr; 61(4):467-75. PubMed ID: 9129564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylnaltrexone prevents morphine-induced delay in oral-cecal transit time without affecting analgesia: a double-blind randomized placebo-controlled trial.
    Yuan CS; Foss JF; O'Connor M; Toledano A; Roizen MF; Moss J
    Clin Pharmacol Ther; 1996 Apr; 59(4):469-75. PubMed ID: 8612393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of enteric-coated methylnaltrexone in preventing opioid-induced delay in oral-cecal transit time.
    Yuan CS; Foss JF; O'Connor M; Karrison T; Osinski J; Roizen MF; Moss J
    Clin Pharmacol Ther; 2000 Apr; 67(4):398-404. PubMed ID: 10801249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of the potential role of methylnaltrexone in opioid bowel dysfunction.
    Foss JF
    Am J Surg; 2001 Nov; 182(5A Suppl):19S-26S. PubMed ID: 11755893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of intravenous methylnaltrexone on opioid-induced gut motility and transit time changes in subjects receiving chronic methadone therapy: a pilot study.
    Yuan SC; Foss FJ; O'Connor M; Osinski J; Roizen FM; Moss J
    Pain; 1999 Dec; 83(3):631-635. PubMed ID: 10568873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Methylnaltrexone on Ticagrelor-Induced Antiplatelet Effects in Coronary Artery Disease Patients Treated With Morphine.
    Franchi F; Rollini F; Park Y; Hu J; Kureti M; Rivas Rios J; Faz G; Yaranov D; Been L; Pineda AM; Suryadevara S; Soffer D; Zenni MM; Bass TA; Angiolillo DJ
    JACC Cardiovasc Interv; 2019 Aug; 12(16):1538-1549. PubMed ID: 31377269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylnaltrexone for reversal of constipation due to chronic methadone use: a randomized controlled trial.
    Yuan CS; Foss JF; O'Connor M; Osinski J; Karrison T; Moss J; Roizen MF
    JAMA; 2000 Jan; 283(3):367-72. PubMed ID: 10647800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 6β-naltrexol, a peripherally selective opioid antagonist that inhibits morphine-induced slowing of gastrointestinal transit: an exploratory study.
    Yancey-Wrona J; Dallaire B; Bilsky E; Bath B; Burkart J; Webster L; Magiera D; Yang X; Phelps M; Sadee W
    Pain Med; 2011 Dec; 12(12):1727-37. PubMed ID: 22123184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized, Double-Blind Trial of Oral Methylnaltrexone for the Treatment of Opioid-Induced Constipation in Patients with Chronic Noncancer Pain.
    Rauck R; Slatkin NE; Stambler N; Harper JR; Israel RJ
    Pain Pract; 2017 Jul; 17(6):820-828. PubMed ID: 27860208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid-induced delay in gastric emptying: a peripheral mechanism in humans.
    Murphy DB; Sutton JA; Prescott LF; Murphy MB
    Anesthesiology; 1997 Oct; 87(4):765-70. PubMed ID: 9357876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of orally administered methylnaltrexone in decreasing subjective effects after intravenous morphine.
    Yuan CS; Foss JF; O'Connor M; Osinski J; Roizen MF; Moss J
    Drug Alcohol Depend; 1998 Oct; 52(2):161-5. PubMed ID: 9800145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying and Treating Opioid Side Effects: The Development of Methylnaltrexone.
    Moss J
    Anesthesiology; 2019 Jan; 130(1):142-148. PubMed ID: 30277930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tolerability, gut effects, and pharmacokinetics of methylnaltrexone following repeated intravenous administration in humans.
    Yuan CS; Doshan H; Charney MR; O'connor M; Karrison T; Maleckar SA; Israel RJ; Moss J
    J Clin Pharmacol; 2005 May; 45(5):538-46. PubMed ID: 15831777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and Tolerability of Subcutaneous Methylnaltrexone in Patients with Advanced Illness and Opioid-Induced Constipation: A Responder Analysis of 2 Randomized, Placebo-Controlled Trials.
    Nalamachu SR; Pergolizzi J; Taylor R; Slatkin NE; Barrett AC; Yu J; Bortey E; Paterson C; Forbes WP
    Pain Pract; 2015 Jul; 15(6):564-71. PubMed ID: 24815199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extended-release but not immediate-release and subcutaneous methylnaltrexone antagonizes the loperamide-induced delay of whole-gut transit time in healthy subjects.
    Kolbow J; Modess C; Wegner D; Oswald S; Maritz MA; Rey H; Weitschies W; Siegmund W
    J Clin Pharmacol; 2016 Feb; 56(2):239-45. PubMed ID: 26313157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subcutaneous methylnaltrexone for treatment of acute opioid-induced constipation: phase 2 study in rehabilitation after orthopedic surgery.
    Anissian L; Schwartz HW; Vincent K; Vincent HK; Carpenito J; Stambler N; Ramakrishna T
    J Hosp Med; 2012 Feb; 7(2):67-72. PubMed ID: 21998076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of subcutaneous methylnaltrexone on patient-reported constipation symptoms.
    Iyer SS; Randazzo BP; Tzanis EL; Schulman SL; Zhang H; Wang W; Manley AL
    Value Health; 2011 Jan; 14(1):177-83. PubMed ID: 21211500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylnaltrexone bromide: research update of pharmacokinetics following parenteral administration.
    Rotshteyn Y; Boyd TA; Yuan CS
    Expert Opin Drug Metab Toxicol; 2011 Feb; 7(2):227-35. PubMed ID: 21222554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of morphine-induced urinary retention after methylnaltrexone.
    Garten L; Bührer C
    Arch Dis Child Fetal Neonatal Ed; 2012 Mar; 97(2):F151-3. PubMed ID: 22034654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.